Abstract. In the last decade, success after in vitro fertilization process (IVF) 
Introduction


In the last decade, pregnancy rate after IVF has remained almost the same, regardless of a lot of improvements implemented in the stimulation protocols and the progress of the laboratory techniques. That being a major reason, more attention has been paid to the removal of all the pathological states which could possibly have a negative impact on the endometrium receptivity, thus lowering the pregnancy rate after IVF [1, 2] . Hysteroscopy is a superior method in uterus cavum visualization enabling a surgical treatment of the pathological changes within the same act. A remarkable progress has been made with the inclusion of cameras, an optical system and a small sized hysteroscope itself, avoiding thus a cervical dilatation, alleviating pain during the intervention and enabling it to be performed in outpatient conditions, without using anesthesia -office hysteroscopy [3] . It is widely accepted that hysteroscopy is per- formed after failed IVF cycles. However, there is still no agreed consensus on a required hysteroscopy prior to IVF cycle, especially in cases of normal cavum ultrasound findings. Numerous studies provide different data on IVF success when hysteroscopy is performed immediately prior to the IVF procedure [47] .
For all these reasons, the aim of this research was to examine the influence of hysteroscopy on the IVF outcome, both in cases with existing pathological substratum in the uterus cavum and in cases with normal hysteroscopic findings.
Methods
The research was done at the Clinic of Gynecology and Obstetrics of the Clinical Center in Niš, as a prospective study, and it included 225 patients from the National IVF program.
Criteria for inclusion in the research were: less than 40 years of age, FSH < 15 IU/ml, AMH > 0.5, body mass index (BMI) < 30 kg/m², lack of genital infection and favorable karyotype of both partners.
Criteria for exclusion were: presence of chronic systematic disease, existence of hepatitis C or HIV infection, organic pathology of the ovaries, the cause of immune infertility and azoospermia.
The patients were divided in three groups: group of 33 patients who had hysteroscopy performed prior to IVF, with existing uterus cavum pathology treated within the same procedure; II group of 41 patients, with hysteroscopy prior to IVF but with normal hysteroscopic findings; and the III control group of 151 patients with no hysteroscopy.
Hysteroscopy was performed during oral contraceptive therapy, 3050 days before IVF. Saline solution was used as a distension medium and a 5mm Bettocchi office hysteroscope (Karl Storz GmbH and co, Tuttlingen, Germany) with a 5Fr working channel. The patients were in a lithotomy position all with short termed intravenous anesthesia applied. Vaginoscopic approach was used with no ecarter and no cervix traction. Versapoint and Springle electrode (Johnson) were used in cases of polypectomy, septum resections and smaller myomas. In one case only, with a wider myoma, a bipolar resectoscope was used with a 9mm outer cover. Polyps, myomas and unclear lesions were hystopathologically evaluated.
IVF procedure was performed 12 months post oral contraceptive therapy. Long and short protocol with GnRH agonists was used. Serial ultrasound checkups during controlled ovary hyperstimulation (COH) were done with a "Shimatzu" ultrasound device, starting with the 6 th day of stimulation. On finding 2 or more follicles larger than 18mm, patients got 10000 IU Pregnyl injection, and 3436 hours afterwards, a transvaginal oocytes pick-up was performed (OPU). Embryo transfer (ET) was done on the 2 nd , 3 rd or 5 th day after the aspiration, monitored by an ultrasound, putting back 3 embryos at the most. "Cook's" catheter was used for the ET. The same therapy was applied for all patients, after ET: Utrogestan 200mg tablets, 3 times a day; Cardiopirin 100mg tablets, once a day; Dexason 0.5mg tabl., once a day. ßHCG from blood was determined for biochemical verification of pregnancy, 15 days post OPU. Clinical pregnancies were verified by transvaginal ultrasound check up, by visualization of the embryo's cardiac activity, 45 weeks after ET.
This prospective clinical trial was approved by the Ethics Committee. The treatment of the patients included hysteroscopy and a long and short GnRH agonist protocol. Written informed consent was provided from all the patients participating in the study.
The data were processed by standard descriptive statistical methods (average value, percentage representation). The statistical processing was done among defined groups. Continual variables relative to data distribution were compared using Student's t-test, Pearson's χ² test or ANOVA test.
Results
The patients from the examined groups were not significantly different in any of the generally examined parameters (Table 1) .
There are also no statistically significant differences among the groups considering: the number of oocytes, conceived embryos, transferred embryos, and the day of embryo transfer as well ( Table 2 ). The long protocol with agonists was most frequently used in the control group when compared to the I group, at a statistical level of significance p<0.05. Based on the general parameters and the features of the IVF cycle, homogeneity of the groups is present, which makes further results valid for this research.
Presence of pathological states in the group of patients with hysteroscopy was 44.59% (Table 3) , with endometrial polyp as the most common pathological state (63.64%), shown in Graph 1. There is no statistically significant difference in the incidence of uterus cavum pathological states between the first and the next IVF (Table 4) .
Although the implantation rate is higher in hysteroscopic groups 1 and 2, compared to the control group (20.62% vs 23.28% vs 17.31%), and the pregnancy rate as well (45.45% vs 46.34% vs 34.44%), there are no significant differences between the groups. There is no statistically important difference neither in the multiple pregnancy rate nor in the rate of biochemical pregnancy, comparing all the three groups (Table 5) . Significantly higher pregnancy rate is present in I group after the first IVF cycle in comparison to the second IVF in the same group (60.00% vs 23.08%, p<0.05), and also between the first IVF cycle in I group compared to the second IVF in the control group (60.00%vs 27.91%, p<0.05) ( Table 6) .
After hysteroscopic polypectomy, highest pregnancy rate was achieved in comparison to uterus cavum pathological states. However, a number of patients did not allow statistical verification (Table 7) . 
Discussion
Regardless of the quality of embryos, an appropriate endometrial thickness and a successful embryo transfer (ET), unsuccessful implantation remains a major cause of IVF method failure. Repetitive implantation failure (RIF) is defined as no conception after two or more alternate transfers of one or more adequate quality embryos. All uterus cavum pathological states have a negative impact on the implantation rate. Their diagnostics is one of the primary goals before entering the IVF cycle. Our research showed cavum pathology incidence of 44.59% with the largest presence of endometrial polyps, in nearly 2/3 of the cases (63.64%). Fatemi [1] found the frequency of only 11% of uterus pathology, whereas Cenksoy [8] discovered pathological states in 44.9% of the patients. In those two studies, endometrial polyp was the most common, but still in a smaller percentage than in our research, 6-19.7%. In his journal article, Kodaman [9] discovers a post IVF conceiving benefit from hysteroscopic polypectomy, explaining that an endometrial injury during the intervention is a reason of increased endometrial receptivity. Polyp treatment options are: cancellation of the cycle and polypectomy, polypectomy and freezing of embryos with ET after a few months' period, or ignoring the polyps and continuation of the cycle [10] .
Even though the implantation and pregnancy rates after cavum pathology treatment are higher than in the control group, our research did not lead to any statistically significant differences. Comparing the IVF outcomes in the first group of patients with clear hysteroscopic findings, similar percentage can be seen. That is in accordance with numerous studies proving the benefit of performing hysteroscopy prior to IVF with patients having pathological substratum and specifying better IVF results after polypectomy, myomectomy or septum uterus resection [7, 11, 12] .
The influence of hysteroscopy itself on the IVF outcome has been considered for quite a long time, advocating hysteroscopy prior to every IVF cycle. In favor of that, many projects discuss the impact of local endometrial injury during hysteroscopy which brings about endometrial inflammation, thus increasing the endometrial receptivity [13] .
In their meta-analyses, Pundir and El-Toukhy found the proof of the hysteroscopy benefit prior to the first IVF cycle, proving a higher pregnancy rate with women who underwent hysteroscopy procedure [4] . One more research with 480 patients also showed higher pregnancy rates when hysteroscopy was performed before the first IVF [14] . Our study did not provide information about hysteroscopy itself influencing statistically better IVF outcome results. Pregnancy rate in II group is statistically not different from the pregnancy rates neither in I group nor in the control group (46.34% vs 45.45% vs 34.44%).
Latest randomized multicentral studies showed that if the ultrasonography result is normal, there is no increased pregnancy rate after hysteroscopy. They also showed that there is no significant difference even if hysteroscopy is being performed after repetitive failed IVF cycles, unless there are pathological changes in the uterus cavum [5, 6] .
Conclusion
Hysteroscopy is a safe method enabling reliable diagnostics of all uterus cavum pathological states which have a negative impact on the IVF outcome. It allows a simultaneous surgical treatment of the pathological changes within the same procedure and it gives a similar IVF outcome as with patients who have clear cavum 
